SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 411 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,290 | -58.5% | 198 | -60.9% | 0.00% | -66.7% |
| Q4 2022 | $65,697 | +13.3% | 507 | -4.9% | 0.00% | +200.0% |
| Q3 2022 | $58,000 | +5700.0% | 533 | +3035.3% | 0.00% | – |
| Q2 2021 | $1,000 | -99.5% | 17 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $212,000 | -76.0% | 2,840 | -45.1% | 0.00% | -88.9% |
| Q4 2020 | $882,000 | -31.5% | 5,171 | -43.6% | 0.02% | -40.0% |
| Q3 2020 | $1,288,000 | -18.3% | 9,171 | -6.7% | 0.03% | -36.2% |
| Q2 2020 | $1,576,000 | +63.8% | 9,831 | 0.0% | 0.05% | +4.4% |
| Q1 2020 | $962,000 | -25.7% | 9,831 | -1.9% | 0.04% | +21.6% |
| Q4 2019 | $1,294,000 | +71.4% | 10,025 | +1.2% | 0.04% | +27.6% |
| Q3 2019 | $755,000 | -49.3% | 9,910 | +1.1% | 0.03% | -54.0% |
| Q2 2019 | $1,490,000 | +33.5% | 9,806 | +4.7% | 0.06% | +23.5% |
| Q1 2019 | $1,116,000 | +9.2% | 9,362 | 0.0% | 0.05% | +13.3% |
| Q4 2018 | $1,022,000 | – | 9,362 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |